Heron Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.06.22	Heron Therapeutics Announces Publication Showing ZYNRELEF® as the Foundation of a Perioperative Non-Opioid Multimodal Analgesic Regimen Reduced Severe Pain and Opioid Use in Patients Undergoing To... (PR Newswire)
26.05.22	Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference (PR Newswire)
16.05.22	Heron Therapeutics Presents ZYNRELEF® Data at the Society for Obstetric Anesthesia and Perinatology 54th Annual Meeting (PR Newswire)
09.05.22	Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates (PR Newswire)
08.05.22	Ausblick: Heron Therapeutics gewährt Anlegern Blick in die Bücher (finanzen.net)
03.05.22	Heron Therapeutics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 (PR Newswire)
05.04.22	Heron Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference (PR Newswire)
25.03.22	Heron Therapeutics Secures Pass-through Payment Status for ZYNRELEF® from Centers for Medicare & Medicaid Services, Expanding Separate Reimbursement into the Hospital Outpatient Setting of Care (PR Newswire)
17.03.22	Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain (PR Newswire)
02.03.22	Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference (PR Newswire)
28.02.22	Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Recent Corporate Updates (PR Newswire)
27.02.22	Ausblick: Heron Therapeutics präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
22.02.22	Heron Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022 (PR Newswire)
09.12.21	Heron Therapeutics: FDA Approves Expanded Indication For ZYNRELEF (RTTNews)
09.12.21	Heron Therapeutics Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF® (PR Newswire)
18.11.21	Heron Therapeutics Announces Submission of HTX-019 NDA for the Prevention of Postoperative Nausea and Vomiting to FDA (PR Newswire)
11.11.21	Heron Therapeutics to Present at Upcoming Investor Conferences (PR Newswire)
03.11.21	Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Recent Corporate Updates (PR Newswire)
28.10.21	Heron Therapeutics to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021 (PR Newswire)
04.10.21	Heron Therapeutics Announces Filing of a Supplemental New Drug Application for Significant Expansion of ZYNRELEF® Indication Statement Based on Successful Outcome of FDA Type C Meeting (PR Newswire)
21.09.21	Heron Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference (PR Newswire)
09.08.21	Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Recent Corporate Updates (PR Newswire)
28.07.21	Heron Therapeutics Announces Publication of Results from HOPE (Helping Opioid Prescription Elimination), Showing ZYNRELEF™ Minimizes the Need for Opioids in a Real-World Setting, With 95% of Patie... (PR Newswire)
21.07.21	Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™ (PR Newswire)
06.07.21	Heron Therapeutics Executes Contract With Apexus For Non-opioid Option ZYNRELEF (RTTNews)
06.07.21	Heron Therapeutics Announces 340B Prime Vendor Contract with Apexus for ZYNRELEF™ (PR Newswire)
01.07.21	Heron Says ZYNRELEF Commercially Available In U.S As Extended-release Local Anesthetic (RTTNews)
01.07.21	Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF™ for the Management of Postoperative Pain for up to 72 Hours (PR Newswire)
13.05.21	Heron Therapeutics' Zynrelef Gets FDA Approval For Managing Post-Operative Pain For 72 Hours (RTTNews)
08.09.20	Stock Alert: Heron Therapeutics Shares Up 8% (RTTNews)
08.09.20	Heron Announces Alignment With FDA On Next Steps For HTX-011 NDA Resubmission (RTTNews)
30.06.20	FDA Snubs HRTX Again, ICPT Disappoints, KNSA Hits Right Notes, Is The Writing On The Wall For VRCA? (RTTNews)
29.06.20	Stock Alert: Heron Therapeutics Slips 30% Following FDA Letter (RTTNews)
29.06.20	Heron Gets CRL For HTX-011 For Management Of Postoperative Pain; Stock Down (RTTNews)
26.05.20	Biotech Stocks Facing FDA Decision In June 2020 (RTTNews)
20.02.20	FDA Delays Decision On HRTX Drug, KPTI On Watch, ADMP To Resubmit NDA In Q2 (RTTNews)
02.05.19	Nabriva, Heron Bleed On FDA Rejection (RTTNews)
26.03.19	Biotech Stocks Facing FDA Decision In April (RTTNews)
31.12.18	Heron : FDA Grants Priority Review Designation For NDA For HTX-011; Stock Up (RTTNews)
22.06.18	XBIO Turns Heads, HRTX Hits New High, RYTM In Good Rhythm, SBOT On Watch (RTTNews)
20.03.18	GERN Up 85% So Far This Month, HRTX Soars On Positive Data, CRON On A High (RTTNews)
08.12.17	New Drugs Approved In November (RTTNews)
05.12.17	GALT Faces Big Test Today, ABBV Clears Psoriasis Trial, DEPO Cuts 40% Of Staff (RTTNews)
10.11.17	FDA Approves DVAX's Hep B Vaccine, OMER Catches Eyes, It's 4 For SGEN's Adcetris (RTTNews)
27.10.17	Biotech Stocks Facing FDA Decision In November (RTTNews)
11.09.17	Daily Technical Summary Reports on Healthcare Stocks -- Shire, Aerie Pharma, Heron Therapeutics, and United Therapeutics (PR Newswire)
10.08.17	GLPG's FLORA Blooms, DVAX, ESPR Price Offering, SGMO Abuzz, HRTX On Track (RTTNews)
26.07.17	Drug Makers Stock Performance Review -- Alliqua BioMedical, Aerie Pharma, Shire, and Heron Therapeutics (PR Newswire)
02.06.17	Research Reports Initiation on Drug Makers Stocks -- Immune Pharma, Impax Labs, Heron Therapeutics, and Alimera Sciences (PR Newswire)
19.04.17	Research Reports Initiation on Drug Makers Stocks -- Impax Labs, Sanofi, Heron Therapeutics, and Alimera Sciences (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	79.88	2.70 %	K V
Roche Hldg G	264.40	2.68 %	K V
Lonza Grp	554.20	2.29 %	K V
Swiss Re	134.85	1.70 %	K V
Novartis	90.39	1.61 %	K V
ABB	49.48	-0.26 %	K V
Geberit	513.60	-0.35 %	K V
Sika	216.90	-0.37 %	K V
Kuehne+Nagel Int	208.50	-0.43 %	K V
Holcim	88.08	-0.45 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Heron Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten